NEPG(SZ:000597) Xin Lang Cai Jing·2025-10-28 01:28Core Insights - Northeast Pharmaceutical (000597.SZ) released its Q3 2025 report, indicating that as of October 27, 2025, five institutional investors hold a total of 807 million shares, representing 56.52% of the company's total equity [1] Institutional Holdings - The total institutional holding percentage decreased by 1.38 percentage points compared to the previous quarter [1] - The institutional investors include Jiangxi Fangda Steel Group Co., Ltd., Liaoning Fangda Group Industrial Co., Ltd., Hong Kong Central Clearing Limited, China Merchants Bank Co., Ltd. - Southern CSI 1000 ETF, and Western Lide CSI 1000 Index Enhanced A [1] Public Fund Activity - One public fund, Western Lide CSI 1000 Index Enhanced A, increased its holdings, while another, Southern CSI 1000 ETF, decreased its holdings [1] - A total of 62 public funds did not disclose their holdings this quarter, including notable funds such as Huaxia CSI 1000 ETF and GF CSI 1000 ETF [1] Foreign Investment - One foreign fund, Hong Kong Central Clearing Limited, reduced its holdings by 0.44% compared to the previous quarter [1]